MPM BioImpact is a biotechnology investment firm based in the United States, focusing on building and investing in innovative companies across all stages of drug development. They manage over $3 billion in assets and aim to deliver transformative therapies to patients.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Third-party rankings
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| Strebulaev-Jackson Venture Ranking: Top 50 Biotech VC Firms | 2026 | #31 | No prior edition | B | Performance |
MPM BioImpact is a biotechnology investment firm founded over 30 years ago. It is based in the United States and focuses on building and investing in innovative companies across all stages of drug development. The organization aims to deliver transformative therapies to patients and manages over $3 billion in assets under management (AUM) across various funds, including early-stage venture funds and public equities. MPM BioImpact employs a unique investment approach known as the BIOIMPACT FUND™, targeting companies that aim to improve patient outcomes.
MPM BioImpact invests in both private and public companies involved in the drug development process. Their investment strategy emphasizes transformative therapies for patients suffering from diseases, employing a unique approach known as the BIOIMPACT FUND™, which targets companies that aim to improve patient outcomes.
MPM BioImpact adds value to its portfolio companies by leveraging its extensive experience in biotechnology investment, providing strategic guidance, and facilitating connections within the industry to enhance growth and development.
MPM BioImpact focuses on biotechnology and healthcare companies that are developing transformative therapies. They invest across various stages, from pre-seed to Series C, and look for companies that demonstrate a strong potential for improving patient outcomes.
Founders can submit their pitches through MPM BioImpact's website at mpmcapital.com. It is advisable to include a detailed business plan and information about the team and technology.
MPM BioImpact's unique investment approach, known as the BIOIMPACT FUND™, emphasizes transformative therapies and patient outcomes. Their extensive experience in biotechnology investments allows them to provide valuable strategic guidance to portfolio companies.
MPM BioImpact primarily invests in companies based in the United States, focusing on the biotech and healthcare sectors.
MPM BioImpact actively engages with its portfolio companies, providing strategic guidance and facilitating connections within the industry to enhance growth and development. They often participate in board meetings and support follow-on investments.
While specific check sizes are not disclosed, MPM BioImpact invests across a range of stages, indicating flexibility in their investment amounts based on the needs of the company.
Organizations that do similar work to MPM BioImpact.
InvestorBessemer Venture Partners is a venture capital firm based in Redwood City, California, with additional offices in major cities across the U.S. and internationally. The firm invests in a wide range of sectors, supporting entrepreneurs from early-stage startups to growth-oriented businesses.
InvestorKhosla Ventures is a venture capital firm based in Menlo Park, California, focusing on early-stage investments in technology-driven companies across various sectors, including fintech, healthcare, and sustainability.
InvestorKleiner Perkins is a venture capital firm based in Menlo Park, California, founded in the 1970s. It partners with entrepreneurs across various sectors, providing capital and resources from inception to IPO.
InvestorYour gateway to global alternative investments.
Superscout Pro
Is this page right?Reviewed · How the research works